SEARCH

SEARCH BY CITATION

References

  • ASCHRAFI, A., SADTLER, S., NICULESCU, C., RETTINGER, J. & SCHMALZING, G. (2004). Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes. J. Membr. Biol., 342, 333343.
  • BERTHOIS, Y., KATZENELLENBOGEN, J.A. & KATZENELLENBOGEN, B.S. (1986). Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Nat. Acad. Sci. U.S.A., 83, 24962500.
  • BINDAL, R.D., CARLSON, K.E., KATZENELLENBOGEN, B.S. & KATZENELLENBOGEN, J.A. (1988). Lipophilic impurities, not phenolsulfonphthalein, account for the estrogenic activity in commercial preparations of phenol red. J. Steroid Biochem., 31, 287293.
  • BRAUN, K., RETTINGER, J., GANSO, M., KASSACK, M., HILDEBRANDT, C., ULLMANN, H., NICKEL, P., SCHMALZING, G. & LAMBRECHT, G. (2001). NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors. Naunyn. Schmiedeberg's Arch. Pharmacol., 364, 285290.
  • BROWN, S.G., KIM, Y.C., KIM, S.A., JACOBSON, K.J., BURNSTOCK, G. & KING, B.F. (2001). Actions of a series of PPADS analogs at P2X1 and P2X3 receptors. Drug Dev. Res., 53, 281291.
  • BROWN, S.G., KING, B.F., KIM, Y.C., JANG, S.Y., BURNSTOCK, G. & JACOBSON, K.A. (2000). Activity of novel adenine nucleotide derivatives as agonists and antagonists at recombinant rat P2X receptors. Drug Dev. Res., 49, 253259.
  • BUELL, G., LEWIS, C., COLLO, G., NORTH, R.A. & SURPRENANT, A. (1996). An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J., 15, 5562.
  • CASS, L.J., FREDERIK, W.S. & MONTILLA, E. (1965). Phenolphthalein: a review of the medical literature and a controlled evaluation of its use as a laxative in the treatment of chronic constipation. Curr. Ther. Res. Clin. Exp., 7, 571589.
  • COLLO, G., NORTH, R.A., KAWASHIMA, E., MERLO-PICH, E., NEIDHART, S., SURPRENANT, A. & BUELL, G. (1996). Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci., 16, 24952507.
  • DAVIES, D.L., MACHU, T.K., GUO, Y. & ALKANA, R.L. (2002). Ethanol sensitivity in ATP-gated P2X receptors is subunit dependent. Alcohol Clin. Exp. Res., 26, 773778.
  • EATON, M.J., PAGAN, O.R., HANN, R.M. & ETEROVIC, V.A. (1997). Differential effects of dimethyl sulfoxide on nicotinic acetylcholine receptors from mouse muscle and Torpedo electrocytes. Neurosci. Lett., 230, 163166.
  • ENNION, S.J. & EVANS, R.J. (2001). Agonist-stimulated internalisation of the ligand-gated ion channel P2X1 in rat vas deferens. FEBS Lett., 489, 154158.
  • ERNST, M., SCHMID, C. & FROESCH, E.R. (1989). Phenol red mimics biological actions of estradiol: enhancement of osteoblast proliferation in vitro and of type I collagen gene expression in bone and uterus of rats in vivo. J. Steroid Biochem., 33, 907914.
  • GRADY, L.H., NONNEMAN, D.J., ROTTINGHAUS, G.E. & WELSHONS, W.V. (1991). pH-dependent cytotoxicity of contaminants of phenol red for MCF-7 breast cancer cells. Endocrinolology, 129, 33213330.
  • GREENBERG, S.S., JOHNS, A., KLEHA, J., XIE, J., WANG, Y., BIANCHI, J. & CONLEY, K. (1994). Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. J. Pharmacol. Exp. Ther., 268, 13521361.
  • HONORE, P., MIKUSA, J., BIANCHI, B., MCDONALD, H., CARTMELL, J., FALTYNEK, C. & JARVIS, M.F. (2002). TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics. Pain, 96, 99105.
  • HOPP, L. & BUNKER, C.H. (1993). Lipophilic impurity of phenol red is a potent cation transport modulator. J. Cell Physiol., 157, 594602.
  • JARVIS, M.F., BURGARD, E.C., MCGARAUGHTY, S., HONORE, P., LYNCH, K., BRENNAN, T.J., SUBIETA, A., VAN BIESEN, T., CARTMELL, J., BIANCHI, B., NIFORATOS, W., KAGE, K., YU, H., MIKUSA, J., WISMER, C.T., ZHU, C.Z., CHU, K., LEE, C.H., STEWART, A.O., POLAKOWSKI, J., COX, B.F., KOWALUK, E., WILLIAMS, M., SULLIVAN, J. & FALTYNEK, C. (2002). A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat. Proc. Natl. Acad. Sci. U.S.A., 99, 1717917184.
  • JIANG, L.H., KIM, M., SPELTA, V., BO, X., SURPRENANT, A. & NORTH, R.A. (2003). Subunit arrangement in P2X receptors. J. Neurosci., 23, 89038910.
  • JONES, C.A., VIAL, C., SELLERS, L.A., HUMPHREY, P.P., EVANS, R.J. & CHESSELL, I.P. (2004). Functional regulation of P2X6 receptors by N-linked glycosylation: identification of a novel αβ-methylene ATP-sensitive phenotype. Mol. Pharmacol., 65, 979985.
  • KHAKH, B.S., BURNSTOCK, G., KENNEDY, C., KING, B.F., NORTH, R.A., SEGUELA, P., VOIGT, M. & HUMPHREY, P.P. (2001). International Union of Pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol. Rev., 53, 107118.
  • KING, B.F., KNOWLES, I.D., BURNSTOCK, G. & RAMAGE, A.G. (2004). Investigation of the effects of P2 purinoceptor ligands on the micturition reflex in female urethane-anaesthetized rats. Br. J. Pharmacol., 142, 519530.
  • KING, B.F., LIU, M., BROWN, S.G., KNIGHT, G., TOWNSEND-NICHOLSON, A., DUNN, P.M., WILDMAN, S.S., JACKSON, V.M., CUNNANE, T.C., PFISTER, J., PADILLA, F., FORD, A.P. & BURNSTOCK, G. (2003). P2X receptor blockade by the pH indicator dye, Phenol red. J. Physiol., 547P, C69.
  • KING, B.F., LIU, M., PINTOR, J., GUALIX, J., MIRAS-PORTUGAL, M.T. & BURNSTOCK, G. (1999). Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors. Br. J. Pharmacol., 128, 981988.
  • KING, B.F., PINTOR, J., WANG, S., ZIGANSHIN, A.U., ZIGANSHINA, L.E. & BURNSTOCK, G. (1996a). A novel P1 purinoceptor activates outward K+ current in follicular oocytes of Xenopus laevis. J. Pharmacol. Exp. Ther., 296, 93100.
  • KING, B.F., TOWNSEND-NICHOLSON, A., WILDMAN, S.S., THOMAS, T., SPYER, K.M. & BURNSTOCK, G. (2000). Coexpression of rat P2X2 and P2X6 subunits in Xenopus oocytes. J. Neurosci., 20, 48714877.
  • KING, B.F., WANG, S. & BURNSTOCK, G. (1996b). P2 purinoceptor activated inward currents in Xenopus oocytes. J. Physiol. (London), 494.1, 1728.
  • KING, B.F., WILDMAN, S.S., ZIGANSHINA, L.E., PINTOR, J. & BURNSTOCK, G. (1997). Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor. Br. J. Pharmacol., 121, 14451453.
  • KLAPPERSTÜCK, M., BÜTTNER, C., SCHMALZING, G. & MARKWARDT, F. (2001). Functional evidence of distinct ATP activation sites at the human P2X7 receptor. J. Physiol., 534, 2535.
  • KYM, P.R., HUMMERT, K.L., NILSSON, A.G., LUBIN, M. & KATZENELLENBOGEN, J.A. (1996). Bisphenolic compounds that enhance cell cation transport are found in commercial phenol red. J. Med. Chem., 39, 48974904.
  • LAMBRECHT, G., RETTINGER, J., BAUMERT, H.G., CZECHE, S., DAMER, S., GANSO, M., HILDEBRANDT, C., NIEBEL, B., SPATZ-KUMBEL, G., SCHMALZING, G. & MUTSCHLER, E. (2000). The novel pyridoxal-5′-phosphate derivative PPNDS potently antagonizes activation of P2X1 receptors. Eur. J. Pharmacol., 387, R19R21.
  • LEWIS, C.J., SURPRENANT, A. & EVANS, R.J. (1998). 2′,3′-O-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP) – a nanomolar affinity antagonist at rat mesenteric artery P2X receptor ion channels. Br. J. Pharmacol., 124, 14631466.
  • MULLINS, L.J., TIFFERT, T., VASSORT, G. & WHITTEMBURY, J. (1983). Effects of internal sodium and hydrogen ions and of external calcium ions and membrane potential on calcium entry in squid axons. J. Physiol., 338, 295319.
  • NICKE, A., BAUMERT, H.G., RETTINGER, J., EICHELE, A., LAMBRECHT, G., MUTSCHLER, E. & SCHMALZING, G. (1998). P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels. EMBO J., 17, 30163028.
  • NORTH, R.A. (2002). Molecular physiology of P2X receptors. Physiol. Rev., 82, 10131067.
  • NUTTLE, L.C. & DUBYAK, G.R. (1994). Differential activation of cation channels and non-selective pores by macrophage P2Z purinergic receptors expressed in Xenopus oocytes. J. Biol. Chem., 269, 1398813996.
  • PETROU, S., UGUR, M., DRUMMOND, R.M., SINGER, J.J. & WALSH Jr, J.V. (1997). P2X7 purinoceptor expression in Xenopus oocytes is not sufficient to produce a pore-forming P2Z-like phenotype. FEBS Lett., 411, 339345.
  • RAAM, S. (1992). Screening for hybridomas producing antibodies to steroid hormone receptors: interference from phenol red in the hybridoma culture supernates. Endocrinology, 131, 20242026.
  • RETTINGER, J., ASCHRAFI, A. & SCHMALZING, G. (2000). Roles of individual N-glycans for ATP potency and expression of the rat P2X1 receptor. J. Biol. Chem., 275, 3354233547.
  • SCHORGE, S. & COLQUHOUN, D. (2003). Studies of NMDA receptor function and stoichiometry with truncated and tandem subunits. J. Neurosci., 23, 11511158.
  • VALERA, S., HUSSY, N., EVANS, R.J., ADAMI, N., NORTH, R.A., SURPRENANT, A. & BUELL, G. (1994). A new class of ligand-gated ion channel defined by P2X receptor for extracellular ATP. Nature, 371, 516519.
  • VIRGINIO, C., ROBERTSON, G., SURPRENANT, A. & NORTH, R.A. (1998). Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3, and heteromeric P2X2/3 receptors. Mol. Pharmacol., 53, 969973.
  • WILDMAN, S.S., BROWN, S.G., RAHMAN, M., NOEL, C.A., CHURCHILL, L., BURNSTOCK, G., UNWIN, R.J. & KING, B.F. (2002). Sensitization by extracellular Ca2+ of rat P2X5 receptor and its pharmacological properties compared with rat P2X1. Mol. Pharmacol., 62, 957966.
  • WILDMAN, S.S., KING, B.F. & BURNSTOCK, G. (1999). Modulatory activity of extracellular H+ and Zn2+ on ATP-responses at rP2X1 and rP2X3 receptors. Br. J. Pharmacol., 128, 486492.
  • WOODWARD, J.J., NOWAK, M. & DAVIES, D.L. (2004). Effects of the abused solvent toluene on recombinant P2X receptors expressed in HEK293 cells. Brain Res. Mol. Brain Res., 125, 8695.
  • ZIGANSHIN, A.U., ZIGANSHINA, L.E., KING, B.F. & BURNSTOCK, G. (1995). Characteristics of ecto-ATPase of Xenopus oocytes and the inhibitory actions of suramin on ATP breakdown. Pflügers Archiv., 429, 412418.
  • ZIGANSHIN, A.U., ZIGANSHINA, L.E., KING, B.F., PINTOR, J. & BURNSTOCK, G. (1996). Effects of P2 purinoceptor antagonists on degradation of adenine nucleotides by ecto-nucleotidases in folliculated oocytes of Xenopus laevis. Biochem. Pharmacol., 51, 897901.